Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
Go back to Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights| (NASDAQ: FULC) | Delayed: 3.78 +0.02 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $ | |||
| Open | $3.80 | 52 Week Low | $ | |||
| Day High | $3.80 | P/E | N/A | |||
| Day Low | $3.75 | EPS | $ | |||
| Volume | 261,068 | |||||

